Skip to main navigation

Investor Relations

Overview
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Investor Resources

Event Details

Neumora Second Quarter 2025 Earnings

Aug 6, 2025 4:30 PM EDT

Listen to webcast

Investor Contact

Helen Rubinstein

drafts investors@neumoratx.com

phone_iphone Main Line: (857) 760-0900

Subscribe to our Email Alerts

© Neumora Therapeutics, Inc.

btn >> Footer icons

Search Investors

Search this site